Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
279-301
Author(s):
M. Gaczynska and P.A. Osmulski
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1959-1972
Author(s):
S. Brunelleschi, L. Penengo, M. M. Santoro and G. Gaudino
Gene Regulation by Adhesion-dependent Signal Transduction Pathways
Journal:
Current Genomics
Volume:
3
Page:
437-448
Author(s):
Jill K. Slack
TGFb and its Smad Connection to Cancer
Journal:
Current Genomics
Volume:
3
Page:
449-476
Author(s):
S. Thiagalingam, K- h. Cheng, R. L. Foy, H. J. Lee, D. Chinnappan and J. F. Ponte
Gene Therapy Approaches for the Selective Killing of Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1683-1694
Author(s):
Eva Maria Westphal and Harald von Melchner
Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson
The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
589-603
Author(s):
L. A. Beltz
Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Journal:
Current Genomics
Volume:
3
Page:
245-263
Author(s):
S. Ortega, M. Malumbres and M. Barbacid
Studies of p53 Tumor Suppression Activity in Mouse Models
Journal:
Current Genomics
Volume:
3
Page:
265-283
Author(s):
Dionisio Martin-Zanca
Understanding Mouse Skin Carcinogenesis through Transgenic Approaches
Journal:
Current Genomics
Volume:
3
Page:
335-353
Author(s):
Fernando Larcher, Angel Ramirez, M. Llanos Casanova, Manuel Navarro, Jesus M. Paramio, Paloma Perez, Angustias Page, Mirentxu Santos and Jose L. Jorcano